Published in J Pharm Pharmacol on November 01, 1976
Brain dopamine and serotonin differ in regulation and its consequences. Proc Natl Acad Sci U S A (2012) 1.00
Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission. Br J Pharmacol (2007) 0.89
Amphetamine augments vesicular dopamine release in the dorsal and ventral striatum through different mechanisms. J Neurochem (2013) 0.80
The effects of amfonelic acid and some other central stimulants on mouse striatal tyramine, dopamine and homovanillic acid. Br J Pharmacol (1982) 0.75
Release of histamine from stomach by vagus-stimulating drugs: association with gastric acid secretion. Fed Proc (1966) 1.67
Transport and storage of biogenic amines. Annu Rev Pharmacol (1972) 1.28
The mode of sodium dependency of the adrenergic neuron amide carrier. Evidence for a second, sodium-dependent, optically specific and reserpine-sensitive system. J Pharmacol Exp Ther (1969) 1.20
A kinetic analysis of drugs that inhibit the adrenergic neuronal membrane amine pump. Biochem Pharmacol (1967) 1.09
On the inability to produce supersensitivity to catecholamines in intestinal smooth muscle. J Pharmacol Exp Ther (1969) 1.06
Studies in vitro of amine uptake mechanisms in heart. Biochem Pharmacol (1966) 1.03
Effects of chronic desipramine treatment on rat brain noradrenergic responses to alpha-adrenergic drugs. Eur J Pharmacol (1980) 1.00
Specific binding of reserpine. Association with norepinephrine depletion. Biochem Pharmacol (1969) 1.00
Functional and pharmacological significance of brain dopamine and norepinephrine storage pools. Biochem Pharmacol (1980) 0.98
Trabecular architecture in women and men of similar bone mass with and without vertebral fracture: II. Three-dimensional histology. Bone (2000) 0.96
In vivo monoamine oxidase inhibition by d-amphetamine. Biochem Pharmacol (1980) 0.94
The mode of potassium action on the adrenergic neuron amine transport system. Life Sci (1969) 0.94
Amine uptake and storage mechanisms in the corpus striatum of rat and rabbit. J Pharmacol Exp Ther (1971) 0.93
The relative functional availability of brain noradrenaline and dopamine storage pools. J Pharm Pharmacol (1977) 0.93
Interaction of apomorphine, neuroleptics and stimulants with alpha-methyl-m-tyramine, a false dopaminergic transmitter. Biochem Pharmacol (1974) 0.89
Preservation of thoracic spine microarchitecture by alendronate: comparison of histology and microCT. Bone (2005) 0.87
On the physiological disposition and possible mechanism of the antihypertensive action of debrisoquin. Biochem Pharmacol (1969) 0.85
Effects of zoxazolamine and related centrally acting muscle relaxants on nigrostriatal dopaminergic neurons. Brain Res Bull (1984) 0.84
Specific inhibition by -methyltyrosine of amphetamine-induced amine release from brain. J Pharmacol Exp Ther (1973) 0.84
The mechanism of norepinephrine depletion by reserpine, metaraminol and related agents. The role of monoamine oxidase. Pharmacol Rev (1966) 0.84
Further studies on the nature of persistent reserpine binding: evidence for reversible and irreversible binding. Biochem Pharmacol (1971) 0.83
Distribution of clozapine in the rat: localization in lung. J Pharmacol Exp Ther (1978) 0.83
Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine. Eur J Pharmacol (1982) 0.81
Localization and binding of reserpine in the membrane of adrenomedullary amine storage granules. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.81
The reserpine receptor. Life Sci (1978) 0.81
Dual actions of guanethidine on amine uptake mechanisms in adrenergic neurons. Biochem Pharmacol (1966) 0.80
Differences in norepinephrine and dopamine neurotransmitter storage systems. Brain Res Bull (1979) 0.80
Characteristics of storage and release of metaraminol in the rat heart. Biochem Pharmacol (1972) 0.80
Optical specificity of monoamine oxidase. Life Sci (1966) 0.80
Effects of severe dopamine depletion on dopamine neuronal impulse flow and on tyrosine hydroxylase regulation. Brain Res Bull (1981) 0.79
On the nature of the adrenergic neuron extragranular amine binding site. J Neural Transm (1974) 0.79
Further evidence for a sodium-dependent, optically specific and reserpine-sensitive amine carrier mechanism at the adrenergic neuron. J Pharmacol Exp Ther (1971) 0.78
Midbrain dopamine neurons: differential responses to amphetamine isomers. Brain Res (1981) 0.78
Amfonelic acid, a non-amphetamine stimulant, has marked effects on brain dopamine metabolism but not noradrenaline metabolism: association with differences in neuronal storage systems. J Pharm Pharmacol (1978) 0.78
Evidence for alpha-methyl-m-tyrasmine as a false dopamine-like transmitter. J Pharm Pharmacol (1972) 0.77
Increased sensitivity in a specific fluorometric method for brain histamine. Biochem Pharmacol (1966) 0.77
Interaction of reserpine and ouabain on amine concentrating mechanisms in the adrenergic neurone. Biochem Pharmacol (1967) 0.77
Dopaminergic neuronal responses to a non-amphetamine CNS stimulant. J Neural Transm (1979) 0.76
Comparative effects of clozapine and alpha-adrenoceptor blocking drugs on regional noradrenaline metabolism in rat brain. Eur J Pharmacol (1978) 0.76
On the role of storage granules in the functional utilization of newly synthesized dopamine. J Neural Transm (1976) 0.76
Monoamine oxidase inhibition by (+)-amphetamine in vivo [proceedings]. Br J Pharmacol (1979) 0.75
Amine uptake characteristics of the guinea-pig Auerbach plexus. Br J Pharmacol (1971) 0.75
Differences in amine storage in rat heart and brain. Br J Pharmacol (1974) 0.75
On the mechanism of action of clozapine on the adrenergic neurone. Br J Pharmacol (1976) 0.75
Permeability changes induced in the adrenergic neurone by reserpine. Biochem Pharmacol (1970) 0.75
Association between biochemical and behavioral actions of tricyclic antidepressants. Int J Neuropharmacol (1966) 0.75
On the formation of adrenergic amine storage granules as measured by reserpine labeling. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.75
Species-dependent responsiveness to nonamphetamine central stimulants. Relationship between uptake and release of brain dopamine. Pharmacology (1979) 0.75
Localization and persistence of metaraminol and -methyl-m-tyramine in rat and rabbit brain. J Pharmacol Exp Ther (1971) 0.75
Similar potency ratios of amphetamine optical isomers for inhibition of dopamine uptake by synaptosomes of corpus striatum, olfactory tubercle and prefrontal cortex of the rat. Biochem Pharmacol (1984) 0.75
Role of dopamine storage function in the control of rat striatal tyrosine hydroxylase activity. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.75
On the mode of amine uptake by the Auerbach plexus of guinea pig small intestine. Eur J Pharmacol (1972) 0.75
Evidence for a prime role of newly synthesized dopamine in mesolimbic dopamine areas. J Pharm Pharmacol (1975) 0.75
The chemical determination of histamine. Methods Biochem Anal (1971) 0.75
Regional distribution of persistently bound reserpine in rat brain. Biochem Pharmacol (1971) 0.75
Pimozide: delayed onset of action at rat striatal pre- and postsynaptic dopamine receptors. J Pharmacol Exp Ther (1980) 0.75
Failure to affect tissue reserpine concentrations by alteration of adrenergic nerve activity. Biochem Pharmacol (1971) 0.75
Mechanisms of storage and release of amines. Psychopharmacol Bull (1975) 0.75
Electrophysiological and biochemical responses of noradrenergic neurons to a non-amphetamine CNS stimulant. Brain Res (1979) 0.75
On a prime role for newly synthesized dopamine in striatal function. Eur J Pharmacol (1975) 0.75